MIRA
INFORM REPORT
|
Report Date : |
15.06.2012 |
IDENTIFICATION DETAILS
|
Name : |
HESTER
DIAGNOSTICS PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
66, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Date of
Incorporation : |
09.06.1998 |
|
|
|
|
Com. Reg. No.: |
11-115289 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 0.500 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U85195MH1998PTC115289 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMH07310C |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACH5528F |
|
|
|
|
Legal Form : |
Private Limited
Liability Company |
|
|
|
|
Line of Business
: |
Manufacturers of
Surgical / Medical Instruments and Apparatus. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (50) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 110000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track.
Financially company is doing well. Trade relations are reported as fair.
Business is active. Payments are reported to be regular and as pre the
commitment. The company can be considered for normal business dealings on a usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LOCATIONS
|
Registered Office : |
66, |
|
Tel. No.: |
91-22-22054170 |
|
Fax No.: |
91-22-22088319 |
|
E-Mail : |
|
|
Website : |
DIRECTORS
AS ON 29.09.2011
|
Name : |
Mr. Sanjiv Dinesh
Gandhi |
|
Designation : |
Director |
|
Address : |
22/23, |
|
Date of Birth/Age : |
15.03.1965 |
|
Date of Appointment : |
09.06.1998 |
|
DIN No.: |
00024548 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
L99999GJ1987PLC022333 |
HESTER
BIOSCIENCES LIMITED |
Director |
29-04-87 |
29-04-87 |
- |
Active |
NO |
|
2 |
U45201GJ1995PTC026168 |
HESTER
COATINGS PRIVATE LIMITED |
Director |
01-06-95 |
01-06-95 |
01-10-09 |
Active |
NO |
|
3 |
U01117MH1991PLC063133 |
BIOLINK
HEALTHCARE LIMITED |
Director |
01-08-96 |
01-08-96 |
- |
Active |
NO |
|
4 |
U85195MH1998PTC115289 |
HESTER
DIAGNOSTICS PRIVATE LIMITED |
Director |
09-06-98 |
09-06-98 |
- |
Active |
NO |
|
5 |
U74140GJ2008PTC053801 |
BELL
PACIFIC PROJEX PRIVATE LIMITED |
Director |
06-05-08 |
06-05-08 |
- |
Strike
off |
NO |
|
6 |
U24220GJ2010PTC063082 |
GMM
COATINGS PRIVATE LIMITED |
Director |
30-11-10 |
30-11-10 |
15-12-10 |
Active |
NO |
|
Name : |
Ms. Hetal Sanjiv
Gandhi |
|
Designation : |
Director |
|
Address : |
22/23, |
|
Date of Birth/Age : |
25.09.1970 |
|
Date of Appointment : |
09.06.1998 |
|
DIN No.: |
00024697 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Company/
LLP Status |
Defaulting
status |
|
1 |
U01117MH1991PLC063133 |
BIOLINK
HEALTHCARE LIMITED |
Director |
01-08-96 |
01-08-96 |
Active |
NO |
|
2 |
U85195MH1998PTC115289 |
HESTER
DIAGNOSTICS PRIVATE LIMITED |
Director |
09-06-98 |
09-06-98 |
Active |
NO |
|
Name : |
Mr. Nina Rajiv
Gandhi |
|
Designation : |
Director |
|
Address : |
22/23, |
|
Date of Birth/Age : |
17.03.1963 |
|
Date of Appointment : |
09.06.1998 |
|
DIN No.: |
00024657 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Company/
LLP Status |
Defaulting
status |
|
1 |
U01117MH1991PLC063133 |
BIOLINK
HEALTHCARE LIMITED |
Director |
13-08-91 |
13-08-91 |
Active |
NO |
|
2 |
U85195MH1998PTC115289 |
HESTER
DIAGNOSTICS PRIVATE LIMITED |
Director |
09-06-98 |
09-06-98 |
Active |
NO |
|
Name : |
Mr. Rajiv Dinesh
Gandhi |
|
Designation : |
Director |
|
Address : |
B-3, 399
Apartment, Bokadev, Ahmedabad-380054, Gujarat, India |
|
Date of Birth/Age : |
02.04.1968 |
|
Date of Appointment : |
09.06.1998 |
|
DIN No.: |
00438037 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
L99999GJ1987PLC022333 |
HESTER
BIOSCIENCES LIMITED |
Managing
director |
01-01-09 |
29-04-87 |
- |
Active |
NO |
|
2 |
U01117MH1991PLC063133 |
BIOLINK
HEALTHCARE LIMITED |
Director |
13-08-91 |
13-08-91 |
- |
Active |
NO |
|
3 |
U45201GJ1995PTC026168 |
HESTER
COATINGS PRIVATE LIMITED |
Director |
02-09-95 |
02-09-95 |
01-10-09 |
Active |
NO |
|
4 |
U85195MH1998PTC115289 |
HESTER
DIAGNOSTICS PRIVATE LIMITED |
Director |
09-06-98 |
09-06-98 |
- |
Active |
NO |
|
5 |
U24239GJ2000PTC038922 |
SINSUI
INDIA PRIVATE LIMITED |
Director |
13-11-00 |
13-11-00 |
- |
Active |
NO |
|
6 |
U51100GJ1971PTC001827 |
CAFFIL
PRIVATE LIMITED |
Director |
08-10-02 |
08-10-02 |
- |
Active |
NO |
|
7 |
U74900GJ2009NPL055842 |
YPO
(GUJARAT) |
Director |
06-01-09 |
06-01-09 |
- |
Active |
NO |
|
8 |
L27109GJ1972PLC011500 |
AHMEDABAD
STEEL CRAFT LIMITED |
Director |
29-09-10 |
16-09-09 |
14-04-11 |
Active |
NO |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 29.09.2011
|
Names of Shareholders |
No. of Shares |
|
Sanjiv Dinesh
Gandhi |
49700 |
|
Hetal Sanjiv
Gandhi |
100 |
|
Nina Rajiv Gandhi |
100 |
|
Rajiv Dinesh
Gandhi |
100 |
|
TOTAL |
50000 |
AS ON 29.09.2011
|
Equity Shares
Break Up |
Percentage |
|
Directors or relatives of Directors |
100.00 |
|
TOTAL |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturers of
Surgical / Medical Instruments and Apparatus. |
|
|
|
|
Products : |
·
Diagnostics
Products ·
Medical
Devices |
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Bankers : |
·
Central Bank of India, Tardeo Branch, Matru
Mandir, 278, Jaojee Dadaji Road, Mumbai-400007, Maharashtra, India |
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Nilesh I Dharia Chartered Accountant |
|
Address : |
3-B, 1st Floor, Ismail Building, 381, D. N. Road, Fort,
Mumbai-400001, Maharashtra, India |
|
Pan No.: |
AAAPD6628D |
|
|
|
|
Associates : |
·
Hester Biosciences Limited ·
Biolink Healthcare Limited ·
Aura Medical Technologies |
CAPITAL STRUCTURE
AS ON 31.03.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
100000 |
Equity Shares |
Rs.10/- each |
Rs. 1.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
50000 |
Equity Shares |
Rs.10/- each |
Rs. 0.500
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
0.500 |
0.500 |
0.500 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
29.227 |
23.082 |
16.672 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
29.727 |
23.582 |
17.172 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
27.527 |
25.543 |
17.247 |
|
|
2] Unsecured Loans |
5.664 |
6.305 |
5.052 |
|
|
TOTAL BORROWING |
33.191 |
31.848 |
22.299 |
|
|
DEFERRED TAX LIABILITIES |
0.041 |
0.080 |
0.076 |
|
|
|
|
|
|
|
|
TOTAL |
62.959 |
55.510 |
39.547 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
1.466 |
1.647 |
1.079 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.060 |
0.060 |
0.060 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
29.066
|
18.060 |
17.102 |
|
|
Sundry Debtors |
34.631
|
33.707 |
24.661 |
|
|
Cash & Bank Balances |
20.200
|
17.449 |
12.221 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
10.196
|
7.432 |
7.964 |
|
Total
Current Assets |
94.093
|
76.648 |
61.948 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
24.260
|
16.320 |
16.505 |
|
|
Other Current Liabilities |
0.000
|
0.000 |
0.000 |
|
|
Provisions |
8.400
|
6.525 |
7.035 |
|
Total
Current Liabilities |
32.660
|
22.845 |
23.540 |
|
|
Net Current Assets |
61.433
|
53.803 |
38.408 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
62.959 |
55.510 |
39.547 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
172.260 |
136.721 |
106.850 |
|
|
|
Other Income |
12.933 |
1.263 |
2.082 |
|
|
|
TOTAL (A) |
185.193 |
137.984 |
108.932 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Purchase |
|
90.856 |
78.409 |
|
|
|
Administrative Expenses |
|
35.408 |
25.739 |
|
|
|
Increase / Decrease in Stock |
|
(0.958) |
(5.100) |
|
|
|
TOTAL (B) |
175.848 |
125.306 |
99.048 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
[Including Financial |
12.678 |
9.884 |
|
|
|
|
Expenses ] |
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
|
2.793 |
2.551 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
9.345 |
9.885 |
7.333 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
0.405 |
0.288 |
0.346 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
8.940 |
9.597 |
6.987 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
2.795 |
3.187 |
2.534 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
6.145 |
6.410 |
4.453 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
NA |
16.671 |
12.218 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
NA
|
23.081 |
16.671 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
25.563 |
19.827 |
27.297 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
122.90 |
128.21 |
89.07 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
3.32
|
4.65 |
4.09 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
5.19
|
7.02 |
6.54 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
9.36
|
12.26 |
11.09 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.30
|
0.41 |
0.41 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
2.22
|
2.32 |
2.67 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.88
|
3.36 |
2.63 |
LOCAL AGENCY FURTHER INFORMATION
|
Check List by Info Agents |
Available in Report (Yes / No) |
|
1. Year of Establishment |
Yes |
|
2. Locality of the firm |
Yes |
|
3. Constructions of the firm |
Yes |
|
4. Premises details |
No |
|
5. Type of Business |
Yes |
|
6. Line of Business |
Yes |
|
7. Promoter’s background |
Yes |
|
8. No. of Employees |
No |
|
9. Name of person contacted |
No |
|
10. Designation of contact person |
No |
|
11. Turnover of firm for last three years |
Yes |
|
12. Profitability for last three years |
Yes |
|
13. Reasons for variation <> 20% |
------ |
|
14. Estimation for coming financial year |
No |
|
15. Capital in the business |
Yes |
|
16. Details of sister concerns |
Yes |
|
17. Major suppliers |
No |
|
18. Major customers |
No |
|
19. Payments terms |
No |
|
20. Export / Import details |
Yes |
|
21. Market information |
------ |
|
22. Litigations that the firm / promoter involved |
------ |
|
23. Banking Details |
Yes |
|
24. Banking facility details |
Yes |
|
25. Conduct of the banking account |
------ |
|
26. Buyer visit details |
------ |
|
27. Financials, if provided |
Yes |
|
28. Incorporation details, if applicable |
Yes |
|
29. Last accounts filed at ROC |
Yes |
|
30. Major Shareholders, if available |
Yes |
OPERATIONAL REVIEW
The turnover achieved by the Company for the
current year is Rs. 172.260 millions as compared to Rs. 136.721 millions for
the previous year. Net Profit after Tax for the current year is Rs. 6.145
millions as compared to Rs. 6.410
millions in the previous year.
FORM 8
|
Corporate
identity number of the company |
U85195MH1998PTC115289 |
|
Name of the
company |
HESTER
DIAGNOSTICS PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in |
66, Princess Street, Mumbai – 400002, Maharashtra, India |
|
This form is for |
Modification of
charge |
|
Charge
identification number of the charge to be modified |
90143864 |
|
Type of charge |
Immovable
property Book debts Movable property (not
being pledge) Others |
|
Particular of
charge holder |
Central Bank of India, Tardeo Branch, Matru Mandir, 278, Jaojee Dadaji Road, Mumbai-400007, Maharashtra, India |
|
Nature of
instrument creating charge |
Supplementary
Agreement Deeds of Hypothecation Deeds of
Guarantee |
|
Date of
instrument Creating the charge |
13.12.2011 |
|
Amount secured by
the charge |
Rs. 40.391
Millions |
|
Brief of the
principal terms an conditions and extent and operation of the charge |
Rate of interest Cash Credit :
Base Rate + 3.75% ODBD : Base Rate
+ 3.75% OD against TD :
FD Rate + 1% Terms of repayment Repayable on
Demand Margin Fund Based
Facility: Cash Credit : 25% ODBD : 50% OD against TD :
10% Non Fund Based
Facility: Bank Guarantee :
25% Extent and operation of the charge Enhancement in
Credit Facility Limits: ODBD from Rs.
13.000 Millions to Rs. 17.000 Millions. Bank Guarantee
from Rs. 6.100 Millions to Rs. 9.000 Millions. Hypothecation of
Goods, Stocks, Spares, P and M, BD and Packing Materials. Collateral
Security: Shares : Rs.
3.602 Millions. Deposits : Rs.
15.873 Millions. Surrender Value
of LIC : Rs. 0.228 Million. EM of Flat 406
situated at Dheeraj Sneh SRA CHSL, Bandra (W). Directors
Personal Guarantee. Corporate
Guarantee : M/s. Hester Diagnostics Private Limited and M/s. Bio Link
Healthcare Limited Other As per
Supplementary Agreement, Deeds of Hypothecation and Deeds of Guarantee |
|
Short particulars
of the property charged (Including location of the property) |
Stocks of Raw
Materials including consumable, spares, stores and packing materials, etc;
stock in process and finished goods, both present and future. All the present
and future book debts, outstanding monies, receivables, claims, bills,
rights, to or immovable properties and movable assets. Tangile, movable
properties and assets of whatsoever nature including plants, machineries,
tools and accessories, stores, spares relating to P and M, Furniture’s and
Fixtures, Articles, Office Equipments Computer,
Electrical Installations and things belonging to the borrower and lying and
being at borrower's premises / factories / stores at various locations. Flat No. 406
situated at Dheeraj Sneh SRA CHSL, 30, Pali Road, Bandra (West), Mumbai -
400050 bearing CTS No. F/616 and 617 at village Pali, Bandra, Taluka :
Andheri. |
|
Whether any of
the property or interest therein under reference is not registered in the
name of the company. |
Yes |
|
If yes, in whose
name it is registers |
Flat No 406
Dheeraj Sneh SRA CHSL Bandra West in the name of Biolink Healthcare Limited
and LIC Policy and Shares in name of Directors. |
|
Date of
instrument modifying the charge |
05.10.2010 |
|
Particulars of
the present modification |
Enhancement of
ODBD Limit up to Rs. 17.000 Millions and Bank Guarantee up to Rs. 9.000
Millions. Break Up of Credit Facilities post modification is as follows: Cash Credit : Rs. 10.900 Millions ODBD : Rs. 17.000
Millions OD against
TD : Rs. 3.491 Millions Bank
Guarantee : Rs. 9.000 Millions Total : Rs. 40.391
Millions |
FIXED ASSETS
·
Office
Equipments
·
Plant
and Machineries
·
Furniture
and Fixtures
·
Computers
·
Vehicles
WEBSITE DETAILS
HISTORY
BOSTON
SCIENTIFIC CORPORATION, USA,
set up their Indian operations, BSC India, in mid-1997. They were amongst the
first distributors appointed by them for the city of Mumbai in western India.
They started with their Microvasive Division for the GI Endoscopy and Endo-urology range of
accessories. For the first year of operations, we did a sale of approx. Rs.5.5
million. For the financial year ending of 31 MARCH 2004 they have crossed Rs.17
million in sales for endoscopy accessories. They have a dedicated sales staff
for this range, who are among the best in the region. There was constant
interaction with all the Key Opinion Leaders (KOLs) and they share excellent
relations with them. They were handling Dr. K.M. Mohandas of Tata Memorial Hospital, Mumbai, which
is India’s premier cancer treatment hospital. High cost and re-usability are
the major factors in this segment which has resulted in slower growth over the
past two years.
During the year 1998-99 they
were offered the distribution for the Target
(Neuro Interventional Radiology) and Meadox
(Vascular Surgery) Divisions.
They were responsible for handling Dr. Uday Limaye at KEM Hospital, Mumbai, which is the single largest centre for
neuro-intervention work in India. Starting with a turnover of Rs.5.6 million,
they achieved a sale of Rs.12.5 million for the year 2003-04. This market
segment is amongst the most rapid growing area, as more and more patients are
opting for minimally invasive procedures as compared to open surgery.
They were then offered the
distribution for their SCIMED
(Interventional Cardiology) Division.
Here too, they were responsible for increasing the sales from Rs.3.7 million to
Rs.14 million for the year 2003-04. The premier account of Dr. AB Mehta at Jaslok Hospital and Medical Research Centre,
Mumbai was handled by them. They were also involved in the promotion of TAXUS â, the paclitaxel drug eluting
stent of BSC, which was successfully launched in India during March 2003.
They were always amongst the top
two distributors for BSC in India. In fact, for two years in a row, in 2002 and
2003, they were awarded the GOLDSTOCKIST
AWARD by them, for their excellent performance and contribution towards their
business in India. These were the only two years when the awards were given
out.
In February 2004, BSC India
changed their business model for the Indian market and decided to go direct to
all customers for all their divisions, in India. As a result of this decision,
they have terminated all their distributors in India and from 1st
April 2004, they will be supplying direct to all hospitals / doctors /
patients. They may loose out on the market share as distribution / logistics
management has not been their forte. This would be an ideal time for competing
companies to enter the field and take advantage of the situation.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources including
but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 55.79 |
|
|
1 |
Rs. 86.37 |
|
Euro |
1 |
Rs. 70.07 |
INFORMATION DETAILS
|
Information
Gathered by : |
-- |
|
|
|
|
Report Prepared
by : |
DPT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
--- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
50 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.